EASD 2026: Retatrutide Surpasses Incretin Threshold in T2D Study | Retatrutide News

The TRIUMPH-2 study indicates that retatrutide has exceeded the incretin ceiling in type 2 diabetes treatment. This suggests enhanced efficacy over exis...
Clinical Trials · October 13, 2026